| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 4 securities · passive | ||||||
|
Cabaletta Bio, Inc.
13G/A
CABA · 12674W109
|
9.6% |
11/16/2026
Event 9/30/2026
|
||||
|
Kyverna Therapeutics, Inc.
13G/A
KYTX · 501976104
|
4.8% |
8/14/2026
Event 6/30/2026
|
||||
|
Century Therapeutics, Inc.
13G/A
IPSC · 15673T100
|
4.1% |
11/14/2025
Event 9/30/2025
|
||||
|
Disc Medicine, Inc.
13G/A
IRON · 254604101
|
3.3% |
2/14/2025
Event 12/31/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.